Apricity, a London, UK-based virtual fertility clinic, raised €17m in Series B funding.
The round was led by MTIP, with participation from Iris Ventures. Marc Dietrich joined the board of directors on behalf of MTIP.
The company intends to use the funds to accelerate growth in the UK, expand geographically (to Spain before the end of the year, followed by Germany and Italy), and further develop its technology, even expanding its at-home services to include at-home ultrasound scans in select areas.
Launched in the UK in 2018 by Caroline Noublanche, CEO, and originally incubated by Kamet Ventures, Apricity combines technology and artificial intelligence with personalized care and medical expertise to improve the fertility experience and maximise chances of conception. It achieves this by providing access to fertility advisors and a customised treatment journey for patients, all navigated through a mobile app.
The service assists with every step of the fertility treatment journey, and provides continuous, personalised support through its app.